ITC Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹17,825Cr
- −5% YoY
- −11.1% QoQ
- Net profit
- ₹5,470Cr
- −72.4% YoY
- +9% QoQ
- Margin
- 39%
- +4 pp YoY
- +5 pp QoQ
Based on ITC Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Standalone Gross Revenue Q4 FY26: Rs. 21,463 crore, up 17.5% YoY (Page 43). Quarterly Financials (Q4 FY26) - Standalone:.
From ITC Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Standalone Gross Revenue Q4 FY26: Rs. 21,463 crore, up 17.5% YoY (Page 43)
- Consolidated Gross Revenue Q4 FY26: Rs. 23,626 crore, up 17.1% YoY (Page 45)
- FMCG Others Segment Revenue Q4 FY26: Rs. 6,304 crore, up 15% YoY (Page 29)
- Agri Business Segment Revenue Q4 FY26: Rs. 3,075 crore, down 15.7% YoY due to geopolitical disruptions (Page 35)
- FMCG Cigarettes Segment Revenue Q4 FY26: Rs. 11,066 crore, up 31.7% YoY (Page 47)
2 more points from ITC Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what ITC Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Fundraising & Capital Structure
See what ITC Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
ITC Ltd — Quarterly revenue & net profit
ITC Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 17,825 | 18,765 | -5% | 20,047 | -11.1% |
| Operating profit (EBITDA) | 6,924 | 6,519 | +6.2% | 6,883 | +0.6% |
| Operating margin | 39% | 35% | +4 pp | 34% | +5 pp |
| Profit before tax | 7,173 | 21,489 | -66.6% | 6,754 | +6.2% |
| Net profit (PAT) | 5,470 | 19,808 | -72.4% | 5,018 | +9% |
| EPS (₹) | 4.30 | 15.76 | -72.7% | 3.94 | +9.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹20.3K Cr, net profit ₹4.2K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What ITC's management said in earlier quarters
Others in Diversified FMCG this season
- Hindustan Unilever (Q4 FY26)
1,200 crores ARR), Personal Care premium products, Home Care liquids, and Lifestyle Nutrition (Pages 7, 8, 10, 15). Key concall takeaways from Hindustan…
- Hindustan Foods (Q4 FY26)
Confident to achieve PAT of INR 200-220 crores for FY27, indicating 40-50% growth in PAT compared to FY26. Key concall takeaways from Hindustan Foods Ltd's Q4…
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
ITC Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were ITC Ltd Q4 FY26 results?
Standalone Gross Revenue Q4 FY26: Rs. 21,463 crore, up 17.5% YoY (Page 43). Quarterly Financials (Q4 FY26) - Standalone:.
What is ITC Ltd share price analysis?
ITC Ltd currently shows a neutral. The stock trades at a P/E of 16.6 with a market cap of ₹328,675 Cr. Investors should review the full earnings analysis for detailed insights.
Keep ITC Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
